Targeted dexamethasone nano-prodrug for corneal neovascularization management

Abstract

This study suggests that DPA nano-prodrug occupies advantages of specific targeting ability and improved bioavailability over conventional therapy, and holds great potential for safe and efficient CNV therapy.